• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The invention relates to a composition for application to the skin, the composition comprising the following: a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; and an aqueous carrier. The invention further relates to the use of the composition as a cosmetic product, in particular an anti-aging composition, for example for reducing one or more of wrinkles, sagging skin, pores, skin clefts, dark circles and crow's feet of an individual.
    公开号:BE1025997B1
    申请号:E2019/5032
    申请日:2019-01-18
    公开日:2019-10-25
    发明作者:Robin List
    申请人:Sylphar Nv；
    IPC主号:
    专利说明:

    COSMETIC COMPOSITION FOR CUTANEIC APPLICATION AND USE THEREOF
    FIELD OF THE INVENTION
    The invention is generally in the field of body care compositions, in particular in the field of cosmetics or cosmetics. In particular, the invention relates to a composition for application to the skin and its use as an anti-aging composition.
    BACKGROUND OF THE INVENTION
    Wrinkles, sagging skin, bags, dark circles and dehydration are some of the signs of aging. A large number of anti-aging products are for sale that are aimed at preventing and correcting one or more of these phenomena by the active ingredients they contain. Well-known active ingredients that prevent aging include retinol, hyaluronic acid and antioxidants such as vitamin C and vitamin E. Another family of products is based on adhesive contracting film formers.
    Wrinkles, in their simplest form, are crevasses or valleys in the skin. When an adhesive contracting film former is applied, the skin at the bottom of the trough or slit can be pulled to the surface, causing the skin to look smooth and wrinkle-free. The disadvantages of existing adhesive contracting film-forming products include discomfort caused by skin contraction, skin irritation, cracking of the film when the user uses facial muscles, incompatibility with other cosmetic products in the regime and visibility of the film, which usually whitish and striking.
    Compositions based on the film-forming capacity of sodium silicates have been described in the art. For example, WO 2013/109850 provides a skin smoothing composition comprising: a) about 0.5 to about 4% sodium silicate, measured as silica content (SiO 2 ); b) from about 0.1% to about 4.0% of a polyvalent silicate; c) about 10 to 98% water; and wherein the weight ratio of the sodium silicate to the polyvalent silicate is at least 0.7 and the composition is in the form of an aqueous gel or oil-in-water emulsion. A second composition that smoothes the skin comprises: a) about 0.5 to about 4% sodium silicate, measured as silica content (SiO 2 ); b) from about 0.1% to about 4.0% of a polyvalent silicate; c) from about 1% to about 20% by weight of a plasticizer; d) about 10 to 98% water; and wherein the weight ratio of the sodium silicate plus the polyvalent silicate to plasticizer is less than 1.8 and the composition is in the form of an aqueous gel or oil-in-water emulsion.
    BE2019 / 5032
    Such compositions comprise only up to 4% sodium silicate and up to 4% polyvalent silicate. However, the more sodium silicate is used, the greater the effects on wrinkle reduction. On the other hand, larger amounts of sodium silicate lead to the presence of white residues after application to the skin, more skin irritation and less durable dried film on the skin.
    In view of the above, there remains a need in the art for further and / or improved anti-aging products for application to the skin.
    SUMMARY OF THE INVENTION
    The present inventors have found a composition, in particular a cosmetic composition, that addresses one or more of the aforementioned problems in the art.
    Accordingly, a first aspect of the invention relates to a skin application composition, the composition comprising: a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; and an aqueous carrier.
    The present compositions have an improved texture which allows for a pleasant application to the skin, in particular to one or more of facial skin, skin around the eyes, skin of the neckline and skin of the neck. After application to the skin, such compositions advantageously make it possible to form films with improved texture and optimum flexibility while satisfactorily reducing wrinkles, sagging skin, pores, skin clefts, dark circles and / or crow's feet. Furthermore, the present compositions may comprise larger amounts of soluble silicates and polyvalent silicates without causing a striking effect of whitening on the skin.
    Accordingly, a further aspect relates to the use of the composition as defined herein, as a cosmetic product, preferably as an anti-aging composition.
    A further aspect relates to a method for cosmetically treating one or more of facial skin, skin around the eyes, skin of the neckline and skin of the neck of an individual around one or more of wrinkles, sagging skin, pores, skin clefts, reduce dark circles and crow's feet, including applying the composition as defined herein to the skin of the individual and allowing the composition to dry.
    The above and further aspects and preferred embodiments of the invention are described in the following paragraphs and in the appended claims. The content of the appended claims is hereby specifically included in this description.
    BE2019 / 5032
    DETAILED DESCRIPTION OF THE INVENTION
    As used herein, the singular forms include one, the, and both references to the singular and to the plural, unless the context clearly dictates otherwise.
    The terms comprising, including and including as used herein are synonymous with included, including or including, contained and they are inclusive or with an open end and do not exclude further unnamed members, elements or steps of a method. The terms also include consisting of and consisting essentially of.
    The indication of numerical areas by means of end points includes all numbers and fractions that lie in the respective areas, as well as the end points mentioned.
    The term approximately as used herein when reference is made to a measurable value, such as a parameter, an amount, a duration and the like, is intended to mean variations with respect to the stated value, in particular variations of +/- 10% or less, preferably +/- 5% or less, more preferably +/- 1% or less and even more preferably to comprise +/- 0.1% or less with respect to the stated value, insofar as such variations apply for the disclosed invention. It should be understood that the value to which the assay roughly refers refers to itself also specifically and preferably disclosed.
    Although the term one or more, such as one or more members of a group of members, is clear per se, the term includes, as a further explanation, a reference to one of the members or to two or more of the members, such as for example> 3,> 4,> 5,> 6 or> 7 etc. of the members and to all these members.
    All documents mentioned in the present description are hereby incorporated by reference in their entirety.
    Unless otherwise stated, all terms used to disclose the invention, including technical and scientific terms, have the meaning as would generally be clear to a person skilled in the art to which this invention belongs. As further guidance, definitions of terms may be included to better understand the teaching of the present invention.
    The present inventors have found a composition comprising PEG-75 shea butter glycerides for effectively reducing wrinkles, while having a pleasant texture and allowing the formation of a flexible film on the skin without causing a striking effect of whitening.
    Accordingly, a first aspect of the invention relates to a skin application composition, the composition comprising: a soluble silicate;
    BE2019 / 5032 a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; and an aqueous carrier. Preferably, the composition is formulated as a water-based cream or a water-based gel.
    The terms composition, formulation or preparation may be used interchangeably herein and refer to a mixture of active ingredients.
    The terms active ingredient or active ingredient can be used interchangeably and generally refer to a compound or substance that when provided in an effective amount gives a desired outcome. The desired outcome can be cosmetic, therapeutic and / or prophylactic. An active ingredient can typically yield one or more of such outcomes through interaction with and / or modulation of living cells or organisms.
    The term active / active in the definitions active ingredient or active component refers to pharmacologically active and / or physically active.
    The reference to an active ingredient includes one or more active ingredients, such as two or more, three or more, or four or more, such as five, six, seven, eight or more of the active ingredients. For example, the reference to a thickener comprises one or more thickeners, such as two or more, three or more or four or more, such as five, six, seven, eight or more thickeners.
    In certain embodiments, the composition as disclosed herein may be a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; and comprise, consist essentially of, or consist of an aqueous carrier.
    PEG-75 shea butter glycerides advantageously provide optimum promotion of the flexibility of the soluble silicate film, reduce the whitening effect and allow an improvement in the texture of the composition. The presence of PEG-75shea butter glycerides in the composition as disclosed herein makes it possible to advantageously obtain a composition with an improved texture, while having wrinkled or sagging skin, in particular facial skin, skin around the eyes, decollete skin and skin of the neck, satisfactorily smoothes, firms and lifts. The PEG-75 shea butter glycerides surprisingly allow the addition of larger amounts of soluble silicates and polyvalent silicates in the composition, while after application of the composition to the skin the PEG-75 shea butter glycerides make it possible to form a flexible soluble silicate film, which is not whitish and is therefore invisible.
    The term PEG-75 shea butter glycerides as used herein refers to an ethoxylated (e.g., average molar ratio of 75 moles of ethylene oxide) mono, diglyceride of shea butter.
    BE2019 / 5032
    The term shea butter as used herein refers to a triglyceride (fat) extracted from the nut of the shea tree (Butyrospermum parkii), which grows in West Africa. Shea butter is a fat that is primarily derived from stearic acid and oleic acid fat.
    In certain embodiments, the PEG-75 shea butter glycerides may be Lipex Shea PEG-75.
    In certain embodiments, the composition as disclosed herein may include Lipex Shea PEG-75.
    An example of PEG-75 shea butter glycerides includes Lipex 102 E-75 (AAK Personal Care, Karlshamn, Sweden).
    The Lipex Shea PEG-75 and Lipex 102 E-75 formulations can be used interchangeably herein.
    In certain embodiments, the composition as disclosed herein may comprise from about 0.1% by weight to about 10% by weight of PEG-75 shea butter glycerides, such as Lipex Shea PEG-75. In certain embodiments, the composition as disclosed herein may be from about 0.2% by weight to about 5% by weight, from about 0.5% by weight to about 5% by weight, or from about 0.5% by weight to about 2% by weight. PEG-75 shea butter glycerides, such as Lipex Shea PEG-75.
    The terms% by weight, mass percentage, weight percentage or weight% can be used interchangeably herein and refer to the weight fraction w, times 100. The weight fraction Wj is the ratio of the mass m, of one compound to the mass m to of the mass total mixture (e.g., the composition as disclosed herein), as defined in (1):
    m,
    Wi = - ™ to (1)
    In certain embodiments, the PEG-75 shea butter glycerides can be used in the composition disclosed herein as a flexibility of soluble silicate promoting agent.
    In certain embodiments, the PEG-75 shea butter glycerides can be a flexibility of soluble silicate promoting agent. As mentioned above, the PEG-75 shea butter glycerides allow the addition of larger amounts of soluble silicates to the composition, while allowing the formation of a flexible soluble silicate film after application and drying of the composition on the skin.
    Thus, one aspect relates to a composition for application to the skin, the composition comprising the following: a soluble silicate; a polyvalent silicate; a flexibility of soluble silicate promoting agent; a thickener; a colorant; and an aqueous carrier, wherein the flexibility of soluble silicate promoting agent is PEG-75 shea butter glycerides.
    BE2019 / 5032
    The terms flexibility of soluble silicate promoting agent or flexibility of soluble silicate film promoting agent as used herein refer to a substance that has the flexibility or flexibility of a soluble silicate film formed after application and drying to the skin of a composition comprising the substance, increases.
    Accordingly, one aspect relates to the use of PEG-75 shea butter glycerides as a flexibility of soluble silicate promoting agent.
    The flexibility or flexibility of a soluble silicate film can be determined visually. A composition as disclosed herein, for example a cream, can be applied to, for example, the facial skin, the skin around the eyes, the skin of the neckline and / or the skin of the neck. The composition is allowed to dry to allow the formation of a soluble silicate film. The flexibility of the soluble silicate film can be determined visually after application and drying of the composition as disclosed herein on the skin. For example, after application and drying of the composition as disclosed herein on the skin, the flexibility of the soluble silicate film can be determined for at least 8 hours. The flexibility of the soluble silicate film can be visually determined on the treated skin by determining tearing and / or breaking of the film due to movements and tensions of the skin. The following classes of flexibility can be distinguished. Low flexibility (flexibility class 1): cracks and fractures can be determined visually in the soluble silicate film quickly after application and drying of the composition disclosed herein on the skin; For example, cracks and fractures can be determined visually in the soluble silicate film after application and drying of the composition disclosed herein on the skin in less than 1 hour, for example 5 minutes, 10 minutes, 15 minutes, 30 minutes or 45 minutes. Average flexibility (flexibility class 2): For example, cracks and fractures can be determined visually in the soluble silicate film 1 hour to less than 4 hours after application and drying of the composition disclosed herein on the skin; For example, cracks and fractures can be determined visually in the soluble silicate film 2 hours or 3 hours after application and drying of the composition disclosed herein on the skin. With optimum flexibility (flexibility class 3), cracks and fractures can be visually determined in the soluble silicate film at the earliest 4 hours after application and drying of the composition disclosed herein on the skin; For example, cracks and fractures can be determined visually in the soluble silicate film 4 hours to 8 hours after application and drying of the composition disclosed herein on the skin.
    In certain embodiments, the flexibility of a soluble silicate film comprising PEG-75 shea butter glycerides (e.g., formed after application and drying of a composition as disclosed herein on the skin) can be promoted (i.e., increased) over (i.e., compared to, i.e., compared to the flexibility of a soluble silicate film 7 BE2019 / 5032 without PEG-75 shea butter glycerides (e.g. formed after application and drying of a composition without PEG-75 shea butter glycerides on the skin). As an example, the flexibility of a soluble silicate film comprising PEG-75 shea butter glycerides (e.g. formed after application and drying of a composition as disclosed herein on the skin) can be at least one flexibility class, e.g. one flexibility class or two flexibility classes, relative to (that i.e., compared to) the flexibility of a soluble silicate film without PEG75 shea butter glycerides (e.g. formed after application and drying of a composition without PEG-75 shea butter glycerides on the skin) is promoted (i.e. increased).
    In certain embodiments, the composition as disclosed herein may comprise a further flexibility of soluble silicate promoting agent selected from the group consisting of an oil derivative, a synthetic rubber, and a polyene.
    In certain embodiments of the compositions, use or methods as disclosed herein, the composition as disclosed herein may further comprise an oil derivative. In certain embodiments, the oil derivative may be a derivative of field marsh flour (seed) oil. An oil derivative advantageously makes it possible to increase the flexibility of the soluble silicate film obtained after application and drying of the composition as disclosed herein on the skin.
    In certain embodiments of the compositions, use, or methods as disclosed herein, the composition may further comprise a derivative of arugula flower oil.
    The terms field marsh flower oil or field marsh flower seed oil can be used interchangeably and refer to an edible oil extracted from the seeds of Limnanthes alba (fluffy marsh flower or field marsh flower is the common name).
    The derivative descriptions of field marsh flower oil or field marsh flower oil derivative can be used interchangeably herein.
    In certain embodiments, the derivative of field marsh flour oil can be a lactone.
    In certain embodiments, the oil derivative may be field marsh flower delta lactone. In certain embodiments, the composition as disclosed herein may include field marsh flour delta lactone.
    Field marsh flower delta lactone is an amphoteric compound, which can isomerize as a function of the pH into water-soluble and oil-soluble forms. The molecular configuration of field marsh flower delta lactone ensures its ability to actively participate in tissue rehydration and conditioning.
    8 BE2019 / 5032
    An example of a derivative of field marsh flower (seed) oil is Meadow lactone (Elementis, Cologne, Germany).
    In certain embodiments, the composition as disclosed herein may comprise from about 0.1% by weight to about 10% by weight of an oil derivative, particularly a derivative of arugula flower oil, such as arugula flower delta lactone. In certain embodiments, the composition as disclosed herein may be from about 0.2% by weight to about 5% by weight, from about 0.5% by weight to about 5% by weight, or from about 0.5% by weight to about 2% by weight. of an oil derivative, in particular a derivative of field marsh flower oil, such as field marsh flower delta lactone.
    In certain embodiments, the composition as disclosed herein may comprise a synthetic rubber. Synthetic rubbers advantageously provide good promotion of flexibility of the soluble silicate film obtained after application and drying of the composition as disclosed herein on the skin.
    The term synthetic rubber refers to an artificial elastomer with properties similar to those of natural rubber. Synthetic rubbers are obtained by polymerization or polycondensation of unsaturated monomers. A wide variety of different synthetic rubbers has been developed, demonstrating the different applications and chemical and mechanical properties. Copolymerization of different monomers makes it possible to vary the material properties over a broad spectrum. Polymerization can take place under hot or cold conditions, leading to warm polymers (warm rubber) or cold polymers (cold rubber). Synthetic rubbers are commercially available as pressed bales and square blocks. They are also produced in the form of powdered rubber, talc coated chips, granules and as latex concentrates in liquid form.
    In certain embodiments, the synthetic rubber is a viscous liquid. In certain embodiments, the synthetic rubber is transparent. In certain embodiments, the synthetic rubber is a viscous transparent liquid.
    In certain embodiments, the synthetic rubber can be selected from the group consisting of butyl rubber, styrene-butadiene rubber (SBR), polybutadiene rubber (BR), isoprene rubber (IR) and chloroprene rubber (CR).
    In certain embodiments, the synthetic rubber can be a butyl rubber or a derivative thereof. In certain embodiments, the composition as disclosed herein may comprise a butyl rubber or a derivative thereof.
    BE2019 / 5032
    The term butyl rubber refers to a copolymer of isobutene with isoprene. Butyl rubber is produced by polymerization of about 98% isobutene with about 2% isoprene.
    The terms butyl rubber derivative or butyl rubber derivative can be used interchangeably herein.
    In certain embodiments, the synthetic rubber can be a butyl rubber derivative. In certain embodiments, the composition as disclosed herein may comprise a butyl rubber derivative.
    In certain embodiments, the butyl rubber derivative may be a polyisobutene (PIB). In certain embodiments, the composition as disclosed herein may comprise a PIB.
    The term polyisobutylene, PIB or polyisobutene refers to a homopolymer of isobutene, (i.e., 2-methyl-1-propene).
    Examples of butyl rubber derivatives are products of the Oppanol B series, which are a series of medium or high molecular weight polyisobutenes that have a weight average molecular weight (Mw) between 40,000 and 4,000,000. An example is Oppanol B10 SFN (BASF, Ludwigshafen, Germany).
    In certain embodiments, the composition as disclosed herein may comprise from about 0.1% to about 10% by weight of a synthetic rubber, in particular a butyl rubber derivative. In certain embodiments, the composition as disclosed herein may be from about 0.2% by weight to about 5% by weight, from about 0.5% by weight to about 5% by weight, or from about 0.5% by weight to about 2% by weight. of a synthetic rubber derivative, in particular a butyl rubber derivative.
    In certain embodiments, the composition as disclosed herein may comprise a polyene. Polyenes advantageously provide optimum flexibility of the soluble silicate film obtained after application and drying of the composition as disclosed herein on the skin.
    The term polyene refers to a polyunsaturated organic compound that contains at least three alternating double and single carbon-carbon bonds.
    Examples of polyenes suitable for use in the composition include polyethylene glycols (PEG), such as PEG-400 and PEG-7.
    In certain embodiments, the polyene may be a polydecene, such as a hydrogenated polydecene. In certain embodiments, the composition as disclosed herein may comprise a polydecene, such as a hydrogenated polydecene.
    BE2019 / 5032
    In certain embodiments, the composition as disclosed herein may comprise from about 0.1% by weight to about 10% by weight of a polyene, in particular a polydecene, such as a hydrogenated polydecene. In certain embodiments, the composition as disclosed herein may be from about 0.2% by weight to about 5% by weight, from about 0.5% by weight to about 5% by weight, or from about 0.5% by weight to about 2% by weight. of a derivative of a polyene, in particular a polydecene, such as a hydrogenated polydecene.
    In certain embodiments, the composition as disclosed herein may comprise: a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; an aqueous carrier; and an oil derivative, in particular a derivative of field marsh flour oil. In certain embodiments, the composition may further comprise a synthetic rubber and a polyene. In certain embodiments, the composition may further comprise a butyl rubber and a polyene. In certain embodiments, the composition may further comprise a butyl rubber derivative and a polyene. In certain embodiments, the composition may further comprise a butyl rubber derivative and a hydrogenated polydecene.
    Accordingly, certain embodiments relate to a composition comprising: a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; an aqueous carrier; a derivative of field marsh flower oil; a butyl rubber derivative; and a polyene. Preferably, the polyene is a polydecene, such as a hydrogenated polydecene.
    Thus, in certain embodiments, the composition as disclosed herein comprises: a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; an aqueous carrier; a derivative of field marsh flower oil; a butyl rubber derivative; and a hydrogenated polydecene.
    In certain embodiments, the composition as disclosed herein may comprise from about 0.1 wt% to about 10 wt% flexibility of soluble silicate promoting agent. In certain embodiments, the composition as disclosed herein may comprise from about 0.2% by weight to about 5% by weight flexibility of soluble silicate promoting agent. In certain embodiments, the composition as disclosed herein may comprise from about 0.5 wt% to about 2 wt% flexibility of soluble silicate promoting agent.
    Further related aspects provide the use of: an oil derivative, in particular a derivative of field marsh flower oil; a synthetic rubber, in particular a butyl rubber derivative; and / or a polyene, such as a polydecene, for example a hydrogenated polydecene; as a flexibility of soluble silicate promoting agent.
    BE2019 / 5032
    The composition as disclosed herein comprises a soluble silicate. The soluble silicate advantageously allows film formation after the composition has been applied to the skin and dried, thereby causing skin contraction, leading to immediate reduction of wrinkles, reduction of pores and / or lifting of the skin.
    In certain embodiments, the soluble silicate is a film former. In certain embodiments, the soluble silicate is used as a film former.
    The term film former as used herein refers to a substance or composition that, when applied to the skin and allowed to dry, leaves a flexible, cohesive and continuous coverage. A select group of film formers, including soluble silicates, also adheres to the skin and is even astringent.
    In certain embodiments, the soluble silicate is an adhesive and contracting film former. In certain embodiments, the soluble silicate is used as an adhesive and contracting film former.
    In certain embodiments of the compositions, use or methods as disclosed herein, the soluble silicate may be sodium silicate or potassium silicate. Both are colorless and water-soluble.
    The terms sodium silicate, liquid glass, or water glass can be used interchangeably herein.
    In certain embodiments of the compositions, use or methods as disclosed herein, the soluble silicate may be a sodium silicate solution, a potassium silicate solution, or a combination thereof. In certain embodiments, the composition as disclosed herein may comprise a sodium silicate solution, a potassium silicate solution, or a combination thereof.
    Sodium silicate solutions that can be used in the compositions disclosed herein can have varying ratios between sodium, usually as Na 2 O, and silica, usually as SiO 2 , varying densities or concentrations of sodium metasilicate (Na 2 SiO 3 ) and / or varying ratios of Na 2 O.SiO 2 . Sodium silicate solutions containing Na 2 SiO 3 , but using other sodium silicate compositions or ratios of Na 2 O.SiO 2 , are also useful.
    In certain embodiments, the sodium silicate may be sodium metasilicate (Na 2 SiO 3 ). In certain embodiments, the sodium silicate Na 2 may be O.xSiO 2 , where x is 3 or 4.
    BE2019 / 5032
    An example of a sodium silicate solution includes sodium silicate 38 / 40BE (Caldic Belgium BV, Hemiksem, Belgium).
    Potassium silicate solutions that can be used in the compositions disclosed herein can have varying ratios between potassium, usually as K 2 O, and silica, usually as SiO 2 , varying densities or concentrations of K 2 SiO 3 and / or varying ratios of K 2 O.SiO 2 . Potassium silicate solutions containing K 2 SiO 3 , but using other potassium silicate compositions or ratios of K 2 O.SiO 2 , are also useful.
    In certain embodiments, the potassium silicate can be potassium metasilicate (K 2 SiO 3 ).
    An example of a potassium silicate solution includes Trasol KC-K (BASF).
    In certain embodiments, the soluble silicate comprises silica (SiO 2 ) and one or more of Na 2 O, K 2 O, Na 2 SiO 3 , K 2 SiO 3 , Na 2 O.SiO 2 and K 2 O.SiO 2 .
    In certain embodiments, the composition as disclosed herein may comprise from about 0.1% by weight to about 25% by weight of soluble silicate, measured as silica content (SiO 2 ). In certain embodiments, the composition as disclosed herein can be from about 0.5% to about 25%, about 0.5% to about 20%, about 0.5% to about 15% by weight , from about 0.5% to about 10% or about 1% to about 10% by weight of soluble silicate, measured as silica content.
    The weight percent (wt%) of soluble silicate as used herein refers to the weight percent of the soluble silicate measured as silica content (SiO 2 ). Briefly, the silica content can be determined by calculation based on the molar mass and / or information from Technical data sheets and / or Material Safety Data Sheet (MSDS).
    The composition as disclosed herein comprises a polyvalent silicate. Addition of a polyvalent silicate advantageously improves the thickness and viscosity of the composition and improves the stability of the composition. The polyvalent silicate also counteracts the effect of whitening on the skin and prevents the appearance of cracks in the film after drying the composition on the skin.
    In certain embodiments, the polyvalent silicate can be a silicate clay. In certain embodiments of the compositions, use or methods as disclosed herein, the polyvalent silicate may be a silicate clay selected from the group consisting of lithium magnesium sodium silicate, magnesium aluminum silicate, bentonite, smectite and kaolinite.
    BE2019 / 5032
    In certain embodiments, the composition as disclosed herein may comprise a silicate clay selected from the group consisting of lithium magnesium sodium silicate, magnesium aluminum silicate, bentonite, smectite, and kaolinite.
    In certain embodiments, the polyvalent silicate may be lithium magnesium sodium silicate or magnesium aluminum silicate. In certain embodiments, the composition as disclosed herein may include lithium magnesium sodium silicate or magnesium aluminum silicate.
    In certain embodiments, the polyvalent silicate can be stable at a pH higher than 10.0. In certain embodiments, the polyvalent silicate can be stable at a pH of 10.5 to 14.0. As an example, the polyvalent silicate at a pH of at least 10.5, at least 11.0, at least 11.5, at least 12.0, at least 12.5, at least 13.0 or at least 13, 5 are stable. This makes it possible to prepare a stable composition with a pH higher than 10.0.
    In certain embodiments, the composition as disclosed herein may comprise from about 0.1% to about 10% by weight of polyvalent silicate. In certain embodiments, the composition as disclosed herein may comprise from about 0.5% to about 10%, about 1% to about 10%, or about 2% to about 10%, by weight, of polyvalent silicate.
    In certain embodiments, the weight ratio of the soluble silicate and the polyvalent silicate to flexibility of soluble silicate promoting agent (i.e., PEG-75 shea butter glycerides, oil derivative, synthetic rubber, and / or polyene) may be at least 2.0. As an example, the weight ratio of the soluble silicate and the polyvalent silicate to PEG-75 shea butter glycerides can be at least 2.0. In certain embodiments, the weight ratio of the soluble silicate and the polyvalent silicate to flexibility of soluble silicate promoting agent (i.e., PEG-75 shea butter glycerides, oil derivative, synthetic rubber and / or polyene) may be at least 2.1, at least 2, 2, at least 2.3, at least 2.4 or at least 2.5. In certain embodiments, the weight ratio of the soluble silicate and the polyvalent silicate to flexibility of soluble silicate promoting agent (i.e., PEG-75 shea butter glycerides, oil derivative, synthetic rubber and / or polyene) may be at least 2.6, at least 2, 7, at least 2.8, at least 2.9, at least 3.0, at least 4.0, at least 5.0, at least 6.0, at least 7.0, at least 8.0, at least 9.0, at least 10.0, at least 15.0, at least 20.0 or at least 25.0. A ratio of the weight of the soluble silicate and the polyvalent silicate to flexibility of the soluble silicate promoting agent of at least 2.0 makes it advantageously possible to incorporate large amounts of soluble silicate and polyvalent silicate in the compositions as disclosed herein together with small amounts of flexibility of soluble silicate promoting agent. Therefore, an improved effect on reducing wrinkles can be obtained, while less effect on white
    BE2019 / 5032 are observed on the skin.
    The composition as disclosed herein comprises a thickener. Addition of a thickener improves the stability of the composition, also improves skin feel and in particular helps to prevent tearing of the film after drying the composition on the skin. Any thickener commonly used in cosmetic preparations can be used in the compositions disclosed herein.
    The terms thickener or thickener can be used interchangeably herein and refer to a substance that can increase the viscosity of a liquid without substantially changing its properties.
    In certain embodiments of the compositions, use or methods as disclosed herein, the thickener may be selected from the group consisting of xanthan gum, cellulose gum, hydroxyethyl cellulose, and polyacrylic acid. In certain preferred embodiments, the thickener is a xanthan gum.
    The term xanthan gum refers to water-soluble biopolymer of p- (1,4) -D-glucose. The CAS number for xanthan gum is 11138-66-2.
    Examples of thickeners include Xanthan gum CS (Gova, Antwerp, Belgium) and Rhodicare T (Solvay Novecare).
    The terms cellulose gum, carboxymethyl cellulose (CMC) or tylose powder refer to a cellulose derivative comprising carboxymethyl groups (-CH2-COOH), which are attached to some of the hydroxyl groups of the glucopyranose monomers that form the cellulose backbone. Cellulose gum can be used as its sodium salt, sodium carboxymethyl cellulose. The CAS number of cellulose gum is 9000-11-7.
    The term hydroxyethyl cellulose refers to a cellulose derivative comprising hydroxyethyl (CH 2 CH 2 OH) groups that are attached to some of the hydroxyl groups of the glucopyranose monomers that form the cellulose backbone. The CAS number of hydroxyethyl cellulose is 9004-62-0.
    The terms polyacrylic acid, poly (acrylic acid), PAA or carbomer refer to a synthetic high molecular weight polymer of acrylic acid. The polymer can be a homopolymer of acrylic acid or cross-linked with an allyl ether of pentaerythritol, allyl ether of sucrose or allyl ether of propylene. The CAS number of polyacrylic acid is 9003-01-4.
    In certain embodiments, the thickener may be stable at a pH higher than 10.0. In certain embodiments, the thickener may be stable at a pH of 10.5 to 14.0. As an example, the thickener can be at a pH of at least 10.5, at least 11.0
    BE2019 / 5032 at least 11.5, at least 12.0, at least 12.5, at least 13.0 or at least 13.5 are stable. This makes it possible to prepare a stable composition with a pH higher than 10.0.
    In certain embodiments, the composition as disclosed herein may comprise from about 0.001% to about 5% by weight of thickener, such as xanthan gum. In certain embodiments, the composition as disclosed herein may be from about 0.01% to about 5%, about 0.1% to about 5%, about 0.1% to about 2.5% by weight %, from about 0.1% to about 1% by weight or about 0.1% by weight to about 0.5% by weight of thickener, such as xanthan gum.
    The composition as disclosed herein includes a colorant. Addition of a colorant advantageously masks the effect of whitening if it occurs on the skin after drying of the composition. Any suitable colorant can be added to the composition.
    The terms colorant or pigment can be used interchangeably herein and refer to a substance that can provide a color to a product, such as to the composition as disclosed herein.
    In certain embodiments, the colorant may be a colorant or a combination of colorants that can impart skin color to the composition.
    In certain embodiments of the compositions, use or methods as disclosed herein, the colorant may be selected from the group consisting of CI 19140, CI 16035, CI 77891, CI 74160, CI 15510 and CI 77266. In certain embodiments, the colorant may be a combination of two or more colorants selected from the group consisting of CI 19140, CI 16035, CI 77891, CI 74160, CI 15510 and CI 77266. The combination of two or more colorants selected from the group consisting of CI 19140, CI 16035, CI 77891, CI 74160, CI 15510 and CI 77266 leads to a skin-colored composition and allows the effect of whitening of the composition after to mask drying on the skin. In certain embodiments, the colorants are CI 19140 and CI 16035.
    The terms CI 19140, tartrazine, E102 or FD&C Yellow refer to a synthetic lemon yellow azo dye.
    The terms CI 16035, Allura Red, E129 or FD&C Red 40 refer to a red azo dye.
    The terms CI 77891, titanium dioxide, titanium white or Pigment White 6 (PW6) refer to the naturally occurring oxide of titanium with the chemical formula TiO.
    BE2019 / 5032
    The terms CI 74160 or Phthalocyanine Blue BN refer to a clear crystalline synthetic blue pigment from the group of phthalocyanine dyes.
    The terms CI 15510, acid orange 7, 2-naphthol orange, Orange II, D&C Orange 4 or COLIPA C015 refer to an orange azo dye.
    The terms CI 77266, carbon black, Black 2 or D&C Black 2 refer to a dye consisting of carbon particles.
    Examples of colorants include Tartrazine E102 (Sancolor SA, Barcelona, Spain) and RED 129 (Sancolor SA, Barcelona, Spain).
    In certain embodiments, the composition as disclosed herein may comprise from about 0.0001% by weight to about 1% by weight of colorant. In certain embodiments, the composition as disclosed herein may be from about 0.0005% to about 1%, about 0.001% to about 1%, about 0.005% to about 1%, or about 0%. 01% by weight to about 1% by weight of colorant.
    In certain embodiments, the composition as disclosed herein may also comprise a preservative. A variety of preservatives, in particular water-soluble preservatives, can be added to the composition to improve their shelf life.
    The term preservative refers to a substance that can prevent decomposition of a product, such as the composition disclosed herein, by microbial growth or by undesired chemical changes.
    In certain embodiments of the compositions, use or methods as disclosed herein, the composition as disclosed herein may further comprise a preservative selected from the group consisting of a phenol derivative, an alkyl glyceryl ether derivative, and a urea derivative.
    In certain embodiments, the preservative may be a water-based preservative. Such preservatives advantageously avoid even more effect of whitening on the skin after drying the composition.
    In certain embodiments, the phenol derivative can be phenoxyethanol or phenylethyl alcohol.
    The terms phenoxyethanol or 2-phenoxyethanol refer to a compound with CAS number 122-99-6.
    The terms phenylethyl alcohol, 2-phenylethan-1-ol or 2-phenylethanol refer to a compound with CAS number 60-12-8.
    BE2019 / 5032
    In certain embodiments, the alkyl glyceryl ether derivative can be ethyl hexyl glycerine.
    The terms ethylhexylglycerin, 3 - [(2-ethylhexyl) oxy] -1,2-propanediol or octoxyglycerin refer to a compound of CAS number 70445-33-9.
    In certain embodiments, the urea derivative can be imidazolidinyl urea or diazolidinyl urea.
    The terms imidazolidinyl urea or 1,1'-methylenebis {3- [4- (hydroxymethyl) -2,5-dioxoimidazolidin-4-yl] urea} refer to a compound having CAS number 39236-46-9.
    The terms diazolidinyl urea or 1- [3,4-bis (hydroxymethyl) -2,5-dioxoimidazolidin-4-yl] -1,3 bis (hydroxymethyl) urea refer to a compound having CAS number 78491-02-8.
    In certain embodiments of the compositions, use or methods as disclosed herein, the composition as disclosed herein may further comprise a preservative selected from phenoxyethanol, phenylethyl alcohol, ethylhexyl glycerin, imidazolidinyl urea, diazolidinyl urea, or a combination thereof.
    In certain embodiments, the composition as disclosed herein may include phenoxyethanol, ethylhexyl glycerine or a combination thereof. In certain embodiments, the composition as disclosed herein may include phenoxyethanol and ethylhexyl glycerin.
    Examples of preservatives are phenoxyethanol available from Gova (Antwerp, Belgium) and ethyl hexylglycerin (NEOPRES SC50) available from Gova (Antwerp, Belgium) or Euxyl PE 9010 available from Schülke Inc.
    In certain embodiments, the composition as disclosed herein may comprise from about 0.1% by weight to about 10% by weight of a preservative selected from the group consisting of a phenol derivative, an alkyl glyceryl ether derivative and a urea derivative such as phenoxyethanol and / or ethylhexylglycerin. In certain embodiments, the composition as disclosed herein may be from about 0.2% to about 5% or about 0.5% to about 2% by weight of a preservative selected from the group consisting of a phenol derivative, an alkyl glyceryl ether derivative and a urea derivative, such as phenoxyethanol and / or ethylhexyl glycerine.
    The composition as disclosed herein comprises an aqueous carrier. An aqueous carrier advantageously improves formation of soluble silicate film after application and drying of the composition as disclosed herein on the skin.
    The terms aqueous carrier or aqueous solution generally refer to a solution in which the solvent comprises water, consists essentially of water or consists of water. In certain embodiments, the aqueous carrier comprises at least 1 volume% of water. As an example
    BE2019 / 5032 the aqueous carrier comprises at least 5% by volume, at least 10% by volume, at least 20% by volume, at least% by volume, at least 40% by volume, at least 50% by volume, at least 60 vol.%, At least 70 vol.%, At least 80 vol.%, At least 90 vol.%, At least 95 vol.% Or at least 99 vol.% Water. In certain embodiments, the aqueous carrier consists of water.
    In certain embodiments of the compositions, use or methods as disclosed herein, the aqueous carrier is water.
    In certain embodiments, the composition as disclosed herein may comprise from about 10% to about 98% by weight of the aqueous carrier, such as water. In certain embodiments, the composition as disclosed herein may be from about 20% to about 98%, about 30% to about 98%, about 40% to about 98%, about 50% by weight up to about 98%, about 60% to about 98%, about 60% to about 95% or about 60% to about 90% by weight of the aqueous carrier, such as water, include.
    In certain embodiments, the composition as disclosed herein need not include organic solvents. In certain embodiments, the composition disclosed herein can be prepared in an aqueous carrier without the use of organic solvents. Such conditions advantageously offer greater possibilities for preparing compositions that allow improved formation of the soluble silicate film. Furthermore, the compositions prepared in an aqueous carrier are stable.
    In certain embodiments, the composition as disclosed herein may comprise a plasticizer selected from the group consisting of a non-ionic hydrophobically modified polyurethane; borax; a polyvinyl alcohol; a polystyrene sulfonate sodium salt; a styrene acrylate ammonium methacrylate copolymer; a sugar-based polymer; a composition comprising hydroxyethyl acrylate, sodium acrylate dimethyltaurate copolymer, isohexadecane, and polysorbate 60; and an extract of red algae.
    The term plasticizer generally refers to a substance or composition that produces or promotes plasticity or viscosity of a material.
    In certain embodiments, the composition as disclosed herein may comprise borax.
    The terms borax or boric acid as used herein refer to a weak boric Lewis basic acid.
    An example of borax is Borax, which is available from ABC chemicals NV (Nazareth, Belgium).
    In certain embodiments, the composition as disclosed herein may comprise a polyvinyl alcohol.
    BE2019 / 5032
    The terms polyvinyl alcohol, PVOH or PVA refer to a water-soluble synthetic polymer prepared by polymerizing vinyl acetate and converting the resulting polyvinyl acetate to polyvinyl alcohol. The conversion of polyvinyl acetate to polyvinyl alcohol is usually carried out by base-catalyzed transesterification with ethanol.
    An example of a polyvinyl alcohol is Selvol Ultalux FA, available from Sekisui Specialty Chemicals (USA).
    An example of a non-ionic hydrophobically modified polyurethane is Avalure flex-6, which is available from Unipex (Woluwe-Saint-Lambert, Belgium).
    An example of a polystyrene sulfonate sodium salt is Flexan II, which is available from AkzoNobel (Amsterdam, the Netherlands).
    An example of a styrene-acrylate-ammonium methacrylate copolymer is Syntran 5760, which is available from Interpolymer (MA, USA).
    An example of a sugar-based polymer is Quicklift available from BASF Chemical Company (Antwerp, Belgium).
    An example of a composition comprising hydroxyethyl acrylate, sodium acrylate dimethyltaurate copolymer, isohexadecane and polysorbate 60 is Simulgel, available from Seppic S.A. (Puteaux, France).
    In certain embodiments, the red algae extract may be a carrageenan-based film former, such as Oligogeline, available from Seppic S.A. (Puteaux, France).
    In certain embodiments, the composition as disclosed herein may be from about 0.1% by weight to about 10% by weight of a plasticizer selected from the group consisting of a non-ionic hydrophobically modified polyurethane; borax; a polyvinyl alcohol; a polystyrene sulfonate sodium salt; a styrene-acrylate-ammonium methacrylate copolymer; a sugar-based polymer; a composition comprising hydroxyethyl acrylate, sodium acrylate dimethyltaurate copolymer, isohexadecane, and polysorbate 60; and an extract of red algae. In certain embodiments, the composition as disclosed herein may be from about 0.2% by weight to about 10% by weight, from about 0.5% by weight to about 10% by weight, or from about 1% by weight to about 10% by weight of a plasticizer selected from the group consisting of a non-ionic hydrophobically modified polyurethane; borax; a polyvinyl alcohol; a polystyrene sulfonate sodium salt; a styrene-acrylate-ammonium methacrylate copolymer; a sugar-based polymer; a composition comprising hydroxyethyl acrylate, sodium acrylate dimethyltaurate copolymer, isohexadecane, and polysorbate 60; and an extract of red algae.
    20 BE2019 / 5032
    The compositions as disclosed herein may further comprise skin active components that can provide a beneficial effect on skin care. The beneficial effect on skin care may include beneficial effects associated with skin appearance or composition. The skin-active component can provide an acute (immediate and short-term) beneficial effect and / or a chronic (long-term and long-term) beneficial effect.
    The term skin-active component as used herein refers to an active ingredient that provides a cosmetic and / or therapeutic effect to the area of application to the skin. The skin-active component includes skin brightening agents, anti-acne agents, emollients, non-steroidal anti-inflammatory agents, local anesthetics, artificial tanning agents, antimicrobials and antifungal agents, skin calming agents, sunburn protection agents, skin barrier repair agents, anti-wrinkle agents , skin atrophy active agents, lipids, number inhibitors, number inhibitors, skin sensitizing agents, protease inhibitors, antipruritic agents, hair growth inhibitors, anti-glycemic agents, anti-glycating agents and mixtures thereof.
    In certain embodiments, the composition as disclosed herein may comprise from about 0.001% to about 20% by weight of the skin-active component. As an example, the composition as disclosed herein may be from about 0.01% by weight to about 15% by weight, from about 0.01% by weight to about 10% by weight, or from about 0.1% by weight to about 10% by weight, of the skin active component.
    The type and amount of skin-active component are chosen such that the incorporation of a specific component does not affect the stability of the composition. For example, hydrophilic agents may be included in an amount that is soluble in the aqueous phase, while lipophilic agents may be included in an amount that is soluble in the oil phase.
    The skin-active components include Epidermist P1.5 (Codif, Saint-Malo, France); Affipore, (Provital France SAS); Beautifeye (Sederma SA); Sesaflash TM (Seppic SA, Puteaux, France); Cityguard PE (Codif, Saint-Malo, France); SNAP-8 (Lipotec SA); Eyeseryl (Lipotec SA); Hyalurosmooth LS8998 (BASF); EPS Seafill PA (Codif, Saint-Malo, France); Glycoin (Bitop); and Oligogeline (Seppic SA, Puteaux, France).
    A composition according to a first embodiment may include the following: sodium silicate; lithium magnesium sodium silicate; PEG-75 shea butter glycerides; derivative of field marsh flower oil; xanthan gum; CI 19140; CI 16035; phenoxyethanol; ethylhexyl glycerin; and water. Such a composition provides excellent properties, including
    BE2019 / 5032 Optimal flexibility of the soluble silicate film when applied as a pore composition or when applied to the skin of the eyelid.
    A composition according to a second embodiment can include the following: sodium silicate; lithium magnesium sodium silicate; PEG-75 shea butter glycerides; derivative of field marsh flower oil; butyl rubber derivative; hydrogenated polydecene; xanthan gum; CI 19140; CI 16035; phenoxyethanol; ethylhexyl glycerin; and water. Such a composition advantageously allows optimum flexibility of the soluble silicate film when it is applied to the skin of the neck and décolleté.
    A composition according to a third embodiment can include the following: sodium silicate; magnesium aluminum silicate; PEG-75 shea butter glycerides; xanthan gum; CI 19140; CI 16035; phenoxyethanol; ethylhexyl glycerin; and water. Such a composition provides excellent properties, including optimum flexibility of the soluble silicate film, when applied to dark circles as a composition.
    A composition according to a fourth embodiment can include the following: sodium silicate; magnesium aluminum silicate; PEG-75 shea butter glycerides; derivative of field marsh flower oil; xanthan gum; CI 19140; CI 16035; phenoxyethanol; ethylhexyl glycerin; and water. Such a composition allows optimum flexibility of the soluble silicate film when it is applied as a composition against crow's feet.
    In certain embodiments of the compositions, use or methods as disclosed herein, the composition may include the following:
    - about 0.1% by weight to about 25% by weight of the soluble silicate, measured as silicon dioxide content (SiO 2 );
    - about 0.1% to about 10% by weight of the polyvalent silicate;
    - about 0.1% by weight to about 10% by weight of PEG-75 shea butter glycerides;
    - about 0.001% by weight to about 5% by weight of the thickener;
    - about 0.0001% by weight to about 1% by weight of the colorant; and
    - about 10% to about 98% by weight of the aqueous carrier.
    In certain embodiments, the composition as disclosed herein may comprise from about 0.1% to about 10% by weight of a preservative selected from the group consisting of a phenol derivative, an alkyl glyceryl derivative, and a urea derivative.
    In certain embodiments, the composition of a first embodiment may comprise: about 0.1% by weight to about 25% by weight of sodium silicate; about 0.1 to 22 BE2019 / 5032 wt% to about 10% by weight lithiummagnesiumnatriumsilicaat..; from about 0.1% by weight to about 10% by weight of PEG-75 shea butter glycerides and a derivative of argan flower oil; from about 0.001% to about 5% by weight of xanthan gum; about 0.0001% by weight to about 1% by weight of CI 19140 and CI 16035; from about 0.1% to about 10% by weight of phenoxyethanol and ethyl hexyl glycerine; and about 10% by weight to about 98% by weight of water. In certain embodiments, the composition of a first embodiment may comprise: about 0.5% to about 10% sodium silicate by weight; from about 1% to about 10% by weight of lithium magnesium sodium silicate; from about 0.5% to about 5% by weight of PEG-75 shea butter glycerides and a derivative of field marsh flour oil; from about 0.01% to about 0.5% by weight of xanthan gum; from about 0.001% to about 1% by weight of CI 19140 and CI 16035; from about 0.1% to about 2% by weight of phenoxyethanol and ethylhexyl glycerine; and about 60% by weight to about 98% by weight of water.
    In certain embodiments, the composition of a second embodiment may comprise: about 0.1 wt% to about 25 wt% sodium silicate; from about 0.1% to about 10% by weight of lithium magnesium sodium silicate; from about 0.1 wt% to about 10 wt% of PEG-75 shea butter glycerides, derivative of acacia flour oil, derivative of butyl rubber and hydrogenated polydecene; from about 0.001% to about 5% by weight of xanthan gum; about 0.0001% by weight to about 1% by weight of CI 19140 and CI 16035; from about 0.1% to about 10% by weight of phenoxyethanol and ethyl hexyl glycerine; and about 10% by weight to about 98% by weight of water. In certain embodiments, the composition of a second embodiment may comprise: about 0.5% to about 10% sodium silicate by weight; from about 1% to about 10% by weight of lithium magnesium sodium silicate; from about 0.5% to about 5% by weight of PEG-75 shea butter glycerides, derivative of acacia flour oil, derivative of butyl rubber, and hydrogenated polydecene; from about 0.01% to about 0.5% by weight of xanthan gum; from about 0.001% to about 1% by weight of CI 19140 and CI 16035; from about 0.1% to about 2% by weight of phenoxyethanol and ethylhexyl glycerine; and about 70% by weight to about 98% by weight of water.
    In certain embodiments, the composition of a third embodiment may comprise: about 0.1 wt% to about 25 wt% sodium silicate; from about 0.1% to about 10% by weight of magnesium aluminum silicate; from about 0.1% to about 10% by weight of PEG-75 shea butter glycerides; from about 0.001% to about 5% by weight of xanthan gum; about 0.0001% by weight to about 1% by weight of CI 19140 and CI 16035; from about 0.1% to about 10% by weight of phenoxyethanol and ethyl hexyl glycerine; and about 10% by weight to about 98% by weight of water. In certain embodiments, the composition of a third embodiment may comprise: about 5% to about 25% sodium silicate;
    23 BE2019 / 5032, about 1 wt% to about 10% by weight of magnesium aluminum silicate..; from about 0.5% to about 2% by weight of PEG-75 shea butter glycerides; from about 0.01% to about 0.5% by weight of xanthan gum; from about 0.001% to about 1% by weight of CI 19140 and CI 16035; from about 0.1% to about 2% by weight of phenoxyethanol and ethylhexyl glycerine; and about 50% to about 98% water.
    In certain embodiments, the composition of a fourth embodiment may comprise: about 0.1% to about 25% sodium silicate; from about 0.1% to about 10% by weight of magnesium aluminum silicate; from about 0.1 wt% to about 10 wt% of PEG-75 shea butter glycerides and derivative of field marsh flour oil; from about 0.001% to about 5% by weight of xanthan gum; about 0.0001% by weight to about 1% by weight of CI 19140 and CI 16035; from about 0.1% to about 10% by weight of phenoxyethanol and ethyl hexyl glycerine; and about 10% by weight to about 98% by weight of water. In certain embodiments, the composition of a fourth embodiment may comprise: about 0.5% to about 10% sodium silicate by weight; from about 1% to about 10% by weight of magnesium aluminum silicate; from about 0.5% to about 5% by weight of PEG-75 shea butter glycerides and a derivative of field marsh flour oil; from about 0.01% to about 0.5% by weight of xanthan gum; from about 0.001% to about 1% by weight of CI 19140 and CI 16035; from about 0.1% to about 2% by weight of phenoxyethanol and ethylhexyl glycerine; and about 60% by weight to about 98% by weight of water.
    In certain embodiments, the composition as disclosed herein may be configured for topical administration. In certain embodiments, the composition as disclosed herein may be configured for application to skin containing one or more of wrinkles, sagging skin, pores, skin gaps, dark circles, and crow's feet, particularly on facial skin, skin around the eyes, skin of the eye cleavage and / or skin of the neck.
    The terms administration or application as used herein refer to the route or route by which a substance or composition is brought into contact with the body.
    With respect to application of the composition, the terms topically, locally or locally refer to delivery of the composition to the intended area, such as an area of skin that contains wrinkles, sagging skin, pores, skin clefts, dark circles and / or crow's feet.
    In certain embodiments of the compositions, use or methods as disclosed herein, the composition may be configured for administration to the skin. In certain embodiments, the composition may be configured for administration to one or more of facial skin, skin around the eyes, skin of the neckline and skin of the neck. The facial skin comprises 24 BE2019 / 5032 the skin of the forehead, the cheeks, the nose and the chin. The skin around the eyes includes the skin below and above the eyes, including the eyelids, of an individual.
    The terms cutaneous administration and dermal administration can be used interchangeably and refer to administration to the skin.
    In certain embodiments of the compositions, use or methods as disclosed herein, the composition may be a cream, a gel, an emulsion, a solution, a lotion or a combination thereof. In certain embodiments, the composition as disclosed herein may be a cream or a gel. Preferably, the composition as disclosed herein is a cream.
    In certain embodiments, the composition may be water-based cream or a water-based gel. Preferably, the composition as disclosed herein is an aqueous cream.
    In certain embodiments, the composition as disclosed herein may have a gel texture. The composition as disclosed herein advantageously has a smooth gel texture with improved transparency after application to the skin. In certain embodiments, the composition as disclosed herein may have a skin color, in particular a human skin color. The skin color advantageously masks the film's whitening effect if it is present on the skin of an individual after drying the composition.
    In certain embodiments, the composition as disclosed herein may have a pH higher than
    10.0. In certain embodiments, the composition as disclosed herein may have a pH of 10.5 to 14.0. As an example, the composition as disclosed herein may have a pH of at least 10.5, at least 11.0, at least 11.5, at least 12.0, at least 12.5, at least 13.0 or at least 13 Have 5. Compositions with a pH higher than 10.0 advantageously have improved stability and promote film formation after application and drying of the composition on the skin.
    In certain embodiments, the composition as disclosed herein may be packaged in a volume of 5 ml to 50 ml. In certain embodiments, the composition as disclosed herein may be packaged in a volume of 5 ml to 20 ml or 10 ml to 25 ml. As an example, the composition as disclosed herein may be packaged in a volume of 5 ml to 10 ml, such as in a volume of 8 ml.
    In certain embodiments, the composition as disclosed herein may be packaged in a pump bottle or tube. In certain embodiments, the pump vial or tube may contain a volume of 5 ml to 50 ml of the composition as disclosed herein. In certain embodiments, the pump vial or tube may contain a volume of 5 ml to 20 ml or 10 ml to 25 ml of the composition as disclosed herein. As an example, the vial or the pump 25 BE2019 / tube 5032 can be a volume of 10 ml, 15 ml, 20 ml or 25 ml of the composition as disclosed herein contain.
    A further aspect relates to the use of the composition as disclosed herein as a cosmetic or cosmeceutical product.
    The term cosmetic refers to a substance or composition that is used to promote or change the appearance of the body.
    In certain embodiments, the use of the composition as disclosed herein is an anti-aging composition.
    The term anti-aging composition refers to cosmetic skin care products based on moisturizers that are sold with the promise to make the user look younger by reducing, masking or preventing signs of aging. Signs of skin aging include sagging, wrinkles, discoloration, and poor structure.
    In certain embodiments, the use of the composition as defined herein serves to reduce one or more, such as one, two, three, four, five or all six of wrinkles, sagging skin, pores, skin clefts, dark circles, and crow's feet of an individual . In certain embodiments, the use of the composition as defined herein is for cosmetically treating one or more of wrinkles, sagging skin, pores, skin clefts, dark circles, and crow's feet of an individual.
    In certain embodiments, the use of the composition as defined herein serves to reduce hanging eyelids of an individual. In certain embodiments, the use of the composition as defined herein serves to cosmetically treat hanging eyelids of an individual.
    A further aspect relates to a method for cosmetically treating facial skin, skin around the eyes, skin of the neckline and / or skin of the neck of an individual for reducing one or more of wrinkles, sagging skin, pores, skin clefts , dark circles and crow's feet, comprising applying the composition as defined herein to the skin of an individual and allowing the composition to dry.
    There are many regimens for applying the composition as disclosed herein to the skin. The composition can be applied at least once a day, twice a day or on a more frequent daily basis during a treatment period. The composition can typically be applied in the morning or in the evening for a special occasion (for example, as before leaving home).
    26 BE2019 / 5032
    The step of applying the composition as disclosed herein to the skin of an individual can be performed by topical application to an area containing one or more of wrinkles, sagging skin, pores, skin clefts, dark circles and crow's feet. In certain embodiments, the composition as disclosed herein may be applied to one or more of facial skin, skin around the eyes, skin of the neck and skin of the neckline, for example, to reduce the appearance of one or more of wrinkles, sagging skin, pores, skin fissures, dark circles and crow's feet in these areas.
    In certain embodiments, methods as disclosed herein may begin with a cleaning step. The individual can wash the face, neck, décolleté and / or skin around the eyes with a suitable cleanser and gently dry the skin, for example with a towel. In certain embodiments, the methods disclosed herein may include applying an oil-based moisturizing agent. The non-oil moisturizing agent can be applied to the skin before and / or after application to the skin as disclosed herein.
    In certain embodiments, the methods as disclosed herein include allowing the composition to dry to form a film, in particular a soluble silicate film. Preferably, the film is an adhesive film and / or an astringent film. During the drying step, it is preferred that the individual does not move the treated skin, such as the facial skin, skin around the eyes, skin of the neck and / or skin of the neckline. The drying step can be at least 2 minutes (i.e. at least 120 seconds), at least 2.5 minutes (i.e. at least 150 seconds), at least 3 minutes (i.e. at least 180 seconds), at least 3 5 minutes (that is, at least 210 seconds) or at least 4 minutes (that is, at least 240 seconds). After the drying step, the methods as disclosed herein may include applying other cosmetics.
    A related aspect provides the composition as disclosed herein for use in the treatment of one or more of wrinkles, sagging skin, pores, skin clefts, dark circles and crow's feet in an individual. Therefore, in certain embodiments, the present invention provides a composition comprising: a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; and an aqueous carrier for use in the treatment of one or more of wrinkles, sagging skin, pores, skin clefts, dark circles, and crow's feet in an individual. The use of the composition as disclosed herein advantageously reduces wrinkles, sagging skin, pores, skin clefts, dark circles and crow's feet on the skin of an individual.
    Except where stated, the terms subject or patient can be used interchangeably, and they refer to animals, preferably warm-blooded animals, more preferably 27 BE2019 / 5032 vertebrates, with mammals, even more preferably, still more preferably from primates, and include in the particularly human patients and non-human mammals and primates. Preferred individuals are human individuals.
    The term mammal includes any animal classified as such, including, but not limited to, humans, domestic animals and farm animals, zoo animals, sport animals, pets, companion animals, and laboratory animals, such as, for example, mice, rats, hamsters, rabbits, dogs, cats , guinea pigs, cattle, cows, sheep, horses, pigs and primates, for example monkeys and great apes. Particularly preferred are human individuals, including both sexes and all age categories starting from the age of 18.
    The terms treatment or treatment include both the therapeutic treatment of an already developed disease or condition, such as the therapy of already developed wrinkles, sagging skin, pores, skin clefts, dark circles and / or crow's feet, as well as prophylactic or preventive measures, where the aim is the prevention or reduction of the chances of incidence of an unwanted condition, such as the prevention, development and progression of wrinkles, sagging skin, pores, skin clefts, dark circles and / or crow's feet. Favorable or desired clinical outcomes may include, without limitation, alleviation of one or more symptoms, reduction in disease rate, and the like.
    A further aspect provides a method for preparing a composition as defined herein, comprising blending together a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; and an aqueous carrier.
    In certain embodiments, the methods as disclosed herein may include admixing a further flexibility of soluble silicate film promoting agent selected from the group consisting of an oil derivative, a synthetic rubber, and a polyene.
    In certain embodiments, the methods as disclosed herein may include admixing an oil derivative, in particular a derivative of field marsh flower oil. In certain embodiments, the methods as disclosed herein may include admixing a synthetic rubber and a polyene. In certain embodiments, the methods as disclosed herein may include admixing a derivative of butyl rubber and a polyene. In certain embodiments, the methods as disclosed herein may include admixing a derivative of argan flower oil, a derivative of butyl rubber, and a polyene.
    28 BE2019 / 5032
    In certain embodiments, the methods as disclosed herein may include admixing a preservative selected from the group consisting of a phenol derivative, an alkyl glyceryl ether derivative, and a urea derivative.
    In certain embodiments, the methods as disclosed herein may include admixing a plasticizer selected from the group consisting of a non-ionic hydrophobically modified polyurethane; borax; a polyvinyl alcohol; a polystyrene sulfonate sodium salt; a styrene acrylate ammonium methacrylate copolymer; a polymer based on sugar; a composition comprising hydroxyethyl acrylate, sodium acrylate dimethyltaurate copolymer, isohexadecane, and polysorbate 60; and an extract of red algae.
    In certain embodiments, the methods as disclosed herein may include admixing a skin-active component that can provide a beneficial effect on skin care. In certain embodiments, the methods as disclosed herein may include admixing additional components such as those typically used in topical products.
    A method according to a first embodiment can include the following: mixing sodium silicate together; lithium magnesium sodium silicate; PEG-75 shea butter glycerides; a derivative of field marsh flower oil; xanthan gum; CI 19140; CI 16035; phenoxyethanol; ethylhexyl glycerin; and water.
    In certain embodiments, the methods disclosed herein may include adding the active ingredients (by a cold method) in the following order: water, phenoxyethanol, ethylhexylglycerin, CI 19140, CI 16035, lithium magnesium sodium silicate, xanthan gum, PEG-75 shea butter glycerides, derivative of field marsh flower oil and sodium silicate.
    A method according to a second embodiment may comprise: mixing sodium silicate together; lithium magnesium sodium silicate; PEG-75 shea butter glycerides; derivative of field marsh flower oil; butyl rubber derivative; hydrogenated polydecene; xanthan gum; CI 19140; CI 16035; phenoxyethanol; ethylhexyl glycerin; and water.
    In certain embodiments, the methods disclosed herein may include adding the active ingredients (by a cold method) in the following order: water, phenoxyethanol, ethylhexylglycerin, CI 19140, CI 16035, lithium magnesium sodium silicate, xanthan gum, PEG-75 shea butter glycerides, derivative of farmland flour oil, hydrogenated polydecene, butyl rubber derivative and sodium silicate.
    A method according to a third embodiment can include the following: mixing sodium silicate together; magnesium aluminum silicate; PEG-75 shea butter glycerides; xanthan gum; CI 19140; CI 16035; phenoxyethanol; ethylhexyl glycerin; and water.
    29 BE2019 / 5032
    In certain embodiments, the methods disclosed herein may include adding the active ingredients (by a cold method) in the following order: water, phenoxyethanol, ethylhexylglycerin, CI 19140, CI 16035, magnesium aluminum silicate, xanthan gum, PEG-75 shea butter glycerides, and sodium silicate .
    A method according to a fourth embodiment can include the following: mixing sodium silicate together; magnesium aluminum silicate; PEG-75 shea butter glycerides; derivative of field marsh flower oil; xanthan gum; CI 19140; CI 16035; phenoxyethanol;
    ethylhexyl glycerin; and water.
    In certain embodiments, the methods disclosed herein may include adding the active ingredients (by a cold method) in the following order: water, phenoxyethanol, ethylhexylglycerin, CI 19140, CI 16035, magnesium aluminum silicate, xanthan gum, PEG-75 shea butter glycerides, derivative of field marsh flower oil and sodium silicate.
    The present application also provides aspects and embodiments as indicated in the following Statements:
    Statement 1. A composition for application to the skin, the composition comprising the following: a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; and an aqueous carrier.
    Statement 2. The composition according to statement 1, wherein the composition further comprises an oil derivative; wherein preferably the composition further comprises a derivative of field marsh flower oil.
    Statement 3. The composition according to statement 1 or 2, wherein the composition further comprises a synthetic rubber and a polyene; the composition preferably further comprising a butyl rubber derivative and a polyene.
    Statement 4. The composition according to any of statements 1 to 3, the composition comprising the following:
    - about 0.1% by weight to about 25% by weight of the soluble silicate, measured as silicon dioxide content (SiO 2 );
    - about 0.1% to about 10% by weight of the polyvalent silicate;
    - about 0.1% to about 10% by weight of the PEG-75 shea butter glycerides;
    - about 0.001% by weight to about 5% by weight of the thickener;
    - about 0.0001% by weight to about 1% by weight of the colorant; and / or
    - about 10% to about 98% by weight of the aqueous carrier.
    30 BE2019 / 5032
    Statement 5. The composition according to any of claims 1 to 4, wherein the soluble silicate is sodium silicate or potassium silicate.
    Statement 6. The composition according to any of claims 1 to 5, wherein the soluble silicate is a sodium silicate solution, a potassium silicate solution or a combination thereof.
    Statement 7. The composition according to any of claims 1 to 6, wherein the soluble silicate is silica (SiO 2 ) and one or more of Na 2 O, K 2 O, Na 2 SiO 3 , K 2 SiO 3 , Na 2 O. SiO 2 and K 2 O.SiO 2 .
    Statement 8. The composition according to any of claims 1 to 7, wherein the polyvalent silicate is a silicate clay selected from the group consisting of lithium magnesium sodium silicate, magnesium aluminum silicate, bentonite, smectite and kaolinite.
    Statement 9. The composition according to any of claims 1 to 8, wherein the polyvalent silicate is stable at a pH higher than 10.0.
    Statement 10. The composition according to any of claims 1 to 9, wherein the thickener is selected from the group consisting of xanthan gum, cellulose gum, hydroxyethyl cellulose and polyacrylic acid.
    Statement 11. The composition according to any of claims 1 to 10, wherein the thickener is stable at a pH higher than 10.0.
    Statement 12. The composition according to any of claims 1 to 11, wherein the colorant is selected from the group consisting of CI 19140, CI 16035, CI 77891, CI 74160, CI 15510 and CI 77266.
    Statement 13. The composition according to any of claims 1 to 12, wherein the composition further comprises a preservative selected from the group consisting of a phenol derivative, an alkyl glyceryl ether derivative and a urea derivative; wherein preferably the composition comprises from about 0.1% to about 10% by weight of a preservative selected from the group consisting of a phenol derivative, an alkyl glyceryl ether derivative and a urea derivative.
    Statement 14. The composition of any one of statements 1 to 13, wherein the aqueous carrier is water.
    Statement 15. The composition according to any of claims 1 to 14, wherein the composition is configured for application to the skin, preferably the composition is configured for application to one or more of facial skin, skin around the eyes, decollete skin and skin of the neck.
    BE2019 / 5032
    Statement 16. The composition according to any of claims 1 to 15, wherein the composition is a cream, a gel, an emulsion, a solution, a lotion or a combination thereof, the composition preferably being a cream.
    Statement 17. Use of the composition as defined in any of statements 1 to 16 as a cosmetic product, preferably as an anti-aging composition.
    Statement 18. The use according to statement 17, for reducing one or more of wrinkles, sagging skin, pores, skin clefts, dark circles and crow's feet of an individual.
    Statement 19. A method for cosmetically treating one or more of facial skin, skin around the eyes, decollete skin and neck skin for reducing one or more of wrinkles, sagging skin, pores, skin clefts, dark circles and crow's feet, comprising applying to the skin the composition as defined in any of claims 1 to 16 and allowing the composition to dry.
    Statement 20. A method for preparing a composition as defined in any one of statements 1 to 16, comprising blending together a soluble silicate; a polyvalent silicate; PEG-75 shea butter glycerides; a thickener; a colorant; and an aqueous carrier.
    The aspects and embodiments described above are further supported by the following non-limiting examples.
    EXAMPLES
    Example 1: Composition according to an embodiment of the invention for reducing pores
    An illustrative composition according to an embodiment of the invention is given in
    Table 1. Table 1 lists the components and the amount of each component in the composition. The composition is useful for reducing pores, for example on facial skin. The composition was formulated as a cream.
    Table 1: Composition according to an embodiment of the invention (anti-pore cream)
    Components Trade name Supplier Quantity(g) water Water Brenntag NV, Deerlijk,Belgium 87.3 water (s) sodium silicate Sodium Silicate38 / 40BE Caldic Belgium BV,Hemiksem, Belgium 0.1 phenoxyethanol Phenoxyethanol Gova, Antwerp, Belgium 0.9
    BE2019 / 5032
    Components Trade name Supplier Quantity(g) ethylhexyl glycerin Ethylhexyl glycerin Gova, Antwerp, Belgium 0.1 water, saccharide isomerate, phenoxyethanol Epidermist P1.5 Codif, Saint Malo,France 1 butylene glycol (s) BarosmaBetulina leaf extract (s) citric acid Affipore Provital France SAS 1 lithium magnesium sodiumsilicate Laponite RD BYK Chemie, Wesel,Germany 3 CI 19140 1% solution of tartrazine E102 Sancolor SA, Barcelona,Spain 0.8 CI 16035 1% solution RED 40 Sancolor SA, Barcelona,Spain 0.2 PEG-75 shea butter glycerides Lipex Shea PEG-75 AAK Personal Care,Karlshamn, Sweden 0.2 field marsh flower deltalactone Meadow lactone Elementis Cologne,Germany 0.4 xanthan gum Xanthan gum CS Gova Antwerp, Belgium 5 Total 100
    The weight ratio of the soluble silicate and the polyvalent silicate to flexibility of soluble silicate promoting agent (i.e. PEG-75 shea butter glycerides and field marsh flower delta lactone) was 5.2 (i.e. 3.1 g / 0.6 g ).
    The antipore cream was obtained by adding the active ingredients according to a cold method in the following order: water, phenoxyethanol, ethylhexylglycerin, CI 19140, CI 16035, (water, saccharide isomerate, phenoxyethanol), (butylene glycol (s) Barosma Betulin leaf extract citric acid), lithium magnesium sodium silicate, xanthan gum, PEG-75 shea butter glycerides, field marsh flour oil derivative and (water (s) sodium silicate).
    The antipore cream has a shelf life of 36 months from the production date when it is stored in a dry and cool place (for example below 25 ° C and 55% humidity).
    Example 2: Composition according to an embodiment of the invention for reducing wrinkles on the neck and décolleté
    A second illustrative composition according to an embodiment of the invention is given in Table 2, wherein the components and the amount of each component in the
    BE2019 / 5032 composition. The composition is useful as a composition for application to the skin of the neck and décolleté. The area of the neck and décolleté are subject to tensions and movements. The composition advantageously allows optimum flexibility of the soluble silicate film after application and drying of the composition on the skin of the neck and / or décolleté. The composition is useful for reducing wrinkles. The composition was formulated as a cream.
    Table 2: Composition according to an embodiment (cream for neck and décolleté)
    Components Trade name Supplier Quantity(g) water water Brenntag NV, DeerlijkBelgium 77.1 lithium magnesium sodiumsilicate Laponite RD BYK Chemistry, WeselGermany 8 xanthan gum Xanthan Gum CS Gova Antwerp, Belgium 4 phenoxyethanol Phenoxyethanol Gova Antwerp, Belgium 0.9 ethylhexyl glycerin Ethylhexyl glycerin Gova Antwerp, Belgium 0.1 CI 19140 1% solution of tartrazine E102 Sancolor SA, Barcelona,Spain 0.4 CI 16035 1% solution RED40 Sancolor SA, Barcelona,Spain 0.2 PEG-75shea butter glycerides Lipex Shea PEG-75 AAK Personal Care,Karlshamn, Sweden 0.2 field marsh flower deltalactone Meadow lactone Elementis, Cologne Germany 0.1 polyisobutene Oppanol B 10 SFN BASF, Ludwigshafen,Germany 3 hydrogenated polydecene Alphaflow 20 The Innovation CompanyFrance 2 water (s) sodium silicate Sodium silicate38/40 BE Caldic Belgium BV,Hemiksem, Belgium 4 Total 100
    The weight ratio of the soluble silicate and the polyvalent silicate to flexibility of soluble silicate-promoting agent (i.e., PEG-75 shea butter glycerides, argan-flower-delta-lactone, polyisobutene, and hydrogenated polydecene) was 2.3 (i.e.
    BE2019 / 5032 say 12 g / 5.3 g).
    The cream for neck and décolleté was obtained by adding the active ingredients according to a cold process in the following order: water, phenoxyethanol, ethylhexylglycerin, CI 19140, CI 16035, lithium magnesium sodium silicate, xanthan gum, PEG-75 shea butter glycerides, 5-argan flour oil derivative, hydrogenated polydecene, butyl rubber derivative and (water (s) sodium silicate).
    The cream for neck and décolleté has a shelf life of 36 months from the production date when it is stored in a dry and cool place (for example below 25 ° C and 55% humidity).
    Example 3: Composition according to an embodiment of the present invention for reduction of drooping eyelids
    A third illustrative composition according to an embodiment of the invention is given in Table 3. Table 3 lists the components and the amount of each component in the composition. The composition is useful for application to the eyelids. The composition allows treatment of drooping eyelids. The composition was formulated as a cream.
    Table 3: Composition according to an embodiment (eyelid cream)
    Components Trade name Supplier Quantity(g) water water Brenntag NV, DeerlijkBelgium 81.2 lithium magnesium sodiumsilicate Laponite RD BYK Chemistry, WeselGermany 6.5 xanthan gum Xanthan Gum CS Gova Antwerp, Belgium 2 phenoxyethanol Phenoxyethanol Gova Antwerp, Belgium 0.9 ethylhexyl glycerin Ethylhexyl glycerin Gova Antwerp, Belgium 0.1 CI 19140 1% solution of tartrazine E102 Sancolor SA, Barcelona,Spain 0.7 CI 16035 1% solution RED40 Sancolor SA, Barcelona,Spain 0.3 glycerin (s) AlbiziaJulibrissin bass extract (s) darutoside Beautifeye Sederma S.A. 3 PEG-75 Lipex Shea PEG-75 AAK Personal Care, 0.3
    BE2019 / 5032
    Components Trade name Supplier Quantity(g) shea butter glyceridesKarlshamn, Swedenfield marsh flower deltalactone Meadow lactone Elementis, Cologne,Germany 0.5 glycerin (s) acrylates copolymer & PVP / polycarbamylpolyglyc olester (s) hydrolyzed sesame protein PG propylmethylsilanediol Sesaflash Seppic S.A., PuteauxFrance 2 seawater & water & hydrolysed algine & hydrolysed algae extract & phenoxyethanol & ethylhexylglycerine Cityguard + PE Codif Saint Malo,France 1.5 water (s) sodium silicate Sodium silicate38 / 40BE Caldic Belgium BV,Hemiksem, Belgium 1 Total 100
    The weight ratio of soluble silicate and polyvalent silicate to flexibility of soluble silicate promoting agent (i.e., PEG-75 shea butter glycerides and field marsh flour delta lactone) was 9.4 (i.e., 7.5 g / 0.8 g).
    The eyelid cream was obtained by adding the active ingredients according to a cold process in the following order: water, phenoxyethanol, ethylhexylglycerin, CI 19140, CI 16035, (glycerin (s) Albizia Julibrissin bass extract (s) darutoside), (seawater & water &
    hydrolysed algae & hydrolysed algae extract & phenoxyethanol & ethylhexylglycerin), lithium magnesium sodium silicate, xanthan gum, PEG-75 shea butter glycerides, arganic flour oil derivative, (glycerine (s) acrylate copolymer &
    PVP / polycarbamyl polyglycol ester (s) hydrolyzed sesame protein (PG - propyl methyl silanediol), and (water (s) sodium silicate).
    The eyelid cream has a shelf life of 36 months from the production date when it is stored in a dry and cool place (for example below 25 ° C and 55% humidity).
    BE2019 / 5032
    Example 4: Composition according to an embodiment of the present invention for reducing dark circles
    A fourth illustrative composition according to an embodiment of the present invention is given in Table 4. Table 4 lists the components and the amount of each component in the composition. The composition is useful for reducing dark circles, for example on the skin of the delicate eye zone. The composition was formulated as a cream for eye application.
    Table 4: Composition according to an embodiment (cream against dark circles)
    Components Trade name Supplier Quantity(g) water Water Brenntag NV,Deerlijk, Belgium 75 water (s) sodium silicate Sodium silicate 38/40 BE Caldic Belgium BV,Hemiksem, Belgium 8 water, acetyloctapeptide 3, caprylyl glycol SNAP-8 Lipotec SA 3 water,acetyl tetrapeptide-5 Eyeseryl Lipotec SA 3 magnesium aluminum silicate Veegum T Vanderbilt Minerals,LLC, NY, USA 4 CI 19140 1% Tartazine solution Sancolor SA, Barcelona, Spain 0.6 CI 16035 1% solution Red 40 Sancolor SA, Barcelona, Spain 0.1 phenoxyethanol, ethylhexyl glycerine Euxyl PE 9010 Schülke INC. 1 PEG-75shea butter glycerides Lipex Shea PEG-75 AAK Personal Care,Karlshamn, Sweden 5 xanthan gum Xanthan gum CS Gova, Antwerp,Belgium 0.3 Total 100
    The weight ratio of the soluble silicate and the polyvalent silicate to flexibility of 37 BE2019 / 5032 soluble silicate promoting agent (i.e. PEG-75 shea butter glycerides) was 2.4 (i.e. 12 g / 5 g).
    The cream against dark circles was obtained by adding the active ingredients according to a cold process in the following order: water, (phenoxyethanol, ethylhexylglycerin), CI
    19140, CI16035, (water, acetyloctapeptide-3, caprylyl glycol), (water, acetyltetrapeptide-5), magnesium aluminum silicate, xanthan gum, PEG-75 shea butter glycerides, and (water (s) sodium silicate).
    The cream against dark circles has a shelf life of 36 months from the production date when it is stored in a dry and cool place (for example below 25 ° C and 55% humidity).
    Example 5: Composition according to an embodiment of the invention for reducing crow's feet
    A fifth illustrative composition according to an embodiment of the present invention is provided in Table 5, which lists the components and the amount of each component in the composition. The composition is useful for reducing crow's feet, for example on the skin of the delicate eye area. The composition is formulated for application around the eyes. The composition was formulated as a cream.
    Table 5: Composition according to an embodiment (anti-crow's foot cream)
    Components Trade name Supplier Quantity(g) water Water Brenntag NV,Deerlijk, Belgium 76.05 water (s) sodium silicate Sodium silicate 38/40 BE Caldic BelgiumBV, Hemiksem,Belgium 7 magnesium aluminum silicate Veegum T VanderbiltMinerals, LLC,NY, USA 4.5 water (s) Cassia Angustifolia seed polysaccharide (s) phenoxyethanol (s) hydroxyethyl cellulose Hyalurosmooth LS8998 BASF 3 water (s) Alteromonasferment extract (s) EPS Seafill PA Codif, Saint Malo,France 2
    BE2019 / 5032
    Components Trade name Supplier Quantity(g) phenethyl alcohol water (s) glyceryl glucoside Glycoin Bitop 1.5 PEG-75 shea butter glycerides Lipex Shea PEG-75 AAK PersonalCare, Karlshamn,Sweden 0.3 phenoxyethanol Phenoxyethanol Gova, Antwerp,Belgium 0.9 CI 19140 1% tartrazine solution Sancolor SA,Barcelona, Spain 0.45 CI 16035 1% solution RED 40 Sancolor SA,Barcelona, Spain 0.2 xanthan gum Rhodicare T Solvay Novecare 3.5 ethylhexyl glycerin Ethylhexyl glycerin Gova, Antwerp,Belgium 0.1 water (s) Chondrus Crisp extract (s) 2-phenoxyethanol (s) methyl paraben (s) ethyl paraben (s) propyl paraben (s) Lithothamion Calcareum extract Oligogeline Seppic S.A.Puteaux, France 0.3 field marsh flower delta lactone Meadow lactone Elementis, Cologne,Germany 0.2 Total 100
    The weight ratio of the soluble silicate and the polyvalent silicate to flexibility of soluble silicate promoting agent (i.e., PEG-75 shea butter glycerides and field marsh flower delta lactone) was 23 (i.e., 11.5 g / 0.5 g).
    The anti-crow's foot cream was obtained by adding the active ingredients in a cold process in the following order: water, phenoxyethanol, ethylhexylglycerin, CI 19140, CI 16035, (water (s) Chondrus Crispus extract (s) 2-phenoxyethanol (s) methylparaben (s) ethylparaben (s) propylparaben (s) Lithothamion Calcareum extract), (water (s) Alteromonas ferment extract (s) phenethyl alcohol), (water (s) Cassia Angustifolia10 seed polysaccharide (s) phenoxyethanol (s) hydroxyethylcellulose), (water (s) glyceryl glucoside),
    BE2019 / 5032 magnesium aluminum silicate, xanthan gum, PEG-75 shea butter glycerides, field marsh flour oil derivative and (water (s) sodium silicate).
    The anti-crow's foot cream has a shelf life of 36 months from the production date when it is stored in a dry and cool place (for example below 25 ° C and 55% humidity).
    Example 6: Use of compositions according to embodiments of the invention as anti-aging compositions
    Comparative compositions 1 and 2 were used as comparative examples for the composition of Example 2 (cream for neck and décolleté). Instead of butyl rubber derivative and hydrogenated polydecene, 3% polysorbate 80 (Comparative composition 1) or 3% cyclomethicone (Comparative composition 2) was used as the flexibility of soluble silicate promoting agent in the composition. The compositions were applied to the skin of the neck and décolleté and allowed to dry for 3 minutes.
    Comparative compositions 3 and 4 were used as comparative examples for the composition of Example 5 (crow's-foot cream). Instead of field marsh flower oil derivative, 1% glycerol (Comparative composition 3) or 1% dimethicone 1000 (Comparative composition 4) was used as the flexibility of soluble silicate promoting agent in the composition. The compositions were applied to the skin around the eyes and allowed to dry for 3 minutes.
    For each composition, the flexibility of the skin-soluble soluble silicate film was determined visually for 8 hours. The flexibility was classified as low, medium or optimal as follows:
    - low flexibility which means that less than 1 hour after application and drying of the composition on the skin, cracks and / or fractures were visually determined in the soluble silicate film;
    - average flexibility which means that cracks and / or fractures were visually determined in the soluble silicate film 1 hour to less than 4 hours after application and drying of the composition on the skin;
    - optimum flexibility which means that at the earliest 4 hours after application and drying of the composition on the skin, cracks and / or fractures were visually determined in the soluble silicate film.
    The cream for neck and décolleté according to an embodiment of the invention reduced wrinkles of the skin of the neck and décolleté. Optimal flexibility of the soluble
    BE2019 / 5032 silicate film observed when the neck and décolleté cream was applied according to an embodiment of the invention. When using only the neck and décolletage cream illustrating the invention, cracks and fractures occurred more than 4 hours after applying and drying the composition to the skin of the neck and décolleté. With comparative compositions 1 and 2, a low flexibility of the soluble silicate film was observed.
    The crow's-foot cream according to an embodiment of the invention led to skin smoothing and reduction of crow's-feet around the delicate eye area. Optimum flexibility of the soluble silicate film was observed when the crow's-foot cream illustrating the invention was applied. The use of the crow's-foot cream illustrating the invention led to cracks and fractures more than 4 hours after application and drying of the composition on the delicate eye zone. With comparative compositions 3 and 4, low flexibility of the soluble silicate film was observed.
    权利要求:
    Claims (15)
    [1]
    CONCLUSIONS (retyped)
    A composition for application to the skin, the composition comprising the following:
    a soluble silicate, wherein the soluble silicate is a sodium silicate solution, a potassium silicate solution or a combination thereof;
    a polyvalent silicate, wherein the polyvalent silicate is a silicate clay selected from the group consisting of lithium magnesium sodium silicate, magnesium aluminum silicate, bentonite, smectite and kaolinite;
    PEG-75 shea butter glycerides;
    a thickener, wherein the thickener is selected from the group consisting of xanthan gum, cellulose gum, hydroxyethyl cellulose and polyacrylic acid;
    a colorant, the colorant being selected from the group consisting of Cl 19140, Cl 16035, Cl 77891, Cl 74160, Cl 15510, and Cl 77266; and an aqueous carrier, wherein the composition further comprises a lactone of cornflower flour oil.
    [2]
    The composition of claim 1, wherein the composition further comprises field marsh flower delta lactone.
    [3]
    The composition of claim 1 or 2, wherein the composition further comprises a polyisobutylene and a polyene.
    [4]
    The composition of any one of claims 1 to 3, wherein the composition comprises:
    about 0.1% to about 25% by weight of the soluble silicate, measured as silica content (SiO 2 );
    from about 0.1% to about 10% by weight of the polyvalent silicate;
    from about 0.1% to about 10% by weight of the PEG-75 shea butter glycerides;
    from about 0.001% to about 5% by weight of the thickener;
    about 0.0001% by weight to about 1% by weight of the colorant; and / or about 10% to about 98% by weight of the aqueous carrier.
    [5]
    The composition of any one of claims 1 to 4, wherein the composition further comprises a preservative selected from phenoxyethanol, phenylethyl alcohol, ethylhexyl glycerin, imidazolidinyl urea, diazolidinyl urea or a combination thereof.
    42 BE2019 / 5032
    [6]
    The composition of any one of claims 1 to 5, wherein the composition comprises from about 0.1% to about 10% by weight of a preservative selected from phenoxyethanol, phenylethyl alcohol, ethylhexyl glycerin, imidazolidinyl urea, diazolidinyl urea or a combination thereof.
    [7]
    The composition of any one of claims 1 to 6, wherein the aqueous carrier is water.
    [8]
    The composition of any one of claims 1 to 7, wherein the composition is configured for administration to the skin.
    [9]
    The composition of any one of claims 1 to 8, wherein the composition is configured for administration to one or more of facial skin, skin around the eyes, skin of the neckline and skin of the neck.
    [10]
    The composition of any one of claims 1 to 9, wherein the composition is a cream, a gel, an emulsion, a solution, a lotion or a combination thereof.
    [11]
    The composition of any one of claims 1 to 10, wherein the composition is a cream.
    [12]
    Use of the composition as defined in any one of claims 1 to 11, as a cosmetic product.
    [13]
    The use according to claim 12, as an anti-aging composition.
    [14]
    Use according to claim 12 or 13, for reducing one or more of wrinkles, sagging skin, pores, skin clefts, dark circles and crow's feet of an individual.
    [15]
    A method for cosmetically treating one or more of facial skin, skin around the eyes, skin of the neckline and skin of the neck of an individual to reduce one or more of wrinkles, sagging skin, pores, skin clefts, dark circles and crow's feet, comprising applying the composition as defined in any one of claims 1 to 11 to the skin of the individual and allowing the composition to dry.
    类似技术:
    公开号 | 公开日 | 专利标题
    RU2195926C2|2003-01-10|Dermatological composition
    CN105250154A|2016-01-20|Cosmetic compositions
    JPH09510185A|1997-10-14|Tissue moisturizing and antimicrobial composition
    US20070292459A1|2007-12-20|Halloysite microtubule processes, structures, and compositions
    CA2629979A1|2009-10-25|Novel resveratrol compositions
    EP2739275B1|2019-01-16|Antiseptic composition
    CN108670878B|2021-06-04|Cosmetic composition for resisting skin allergy
    US20200000693A1|2020-01-02|Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents
    CA2931395A1|2015-06-04|Composition of alkyl polyglucosides and fatty esters of cationic amino acids
    WO2018185408A1|2018-10-11|Protective ingredient for balancing the cutaneous and/or mucosal microbial flora
    CN107108905A|2017-08-29|Water-soluble supramolecular complex
    BE1025997B1|2019-10-25|Cosmetic composition for cutaneous application and use thereof
    EP3554462A1|2019-10-23|Method for improving the sensorial properties of oil-in-water emulsions
    JP4869751B2|2012-02-08|Sunburn cell formation inhibitor and DNA damage repair promoter
    AU2009237483B2|2012-05-10|Compositions for the treatment of lice
    US20060210496A1|2006-09-21|Compositions for skin protection from ultraviolet damage
    EP3415142B1|2020-12-09|Composition for the treatment of blepharitis containing terpinen-4-ol
    WO2009071776A2|2009-06-11|Antimicrobial composition that can be used in cosmetics and in dermatology
    FR3063223A1|2018-08-31|OIL-IN-WATER EMULSION COMPRISING ACRYLIC ACID HOMOPOLYMER, ACRYLIC ACID EMULSIFYING POLYMER, CLEANING OIL AND AT LEAST THREE POLYOLS
    FR3068206A1|2019-01-04|ANTIMICROBIAL MIXTURE CONTAINING 4- | BUTAN-2-ONE AND OCTANE-1,2-DIOL, AND COSMETIC COMPOSITION CONTAINING SAME
    JP2018052888A|2018-04-05|Aqueous preparation
    EP3378475A1|2018-09-26|Composition and kit for the use in the prevention of recurrentonychomycosis
    JP4174596B2|2008-11-05|Water-soluble polymer antibacterial agent
    US20200230088A1|2020-07-23|Coloured keratolytic nail lacquer
    US20210220252A1|2021-07-22|Silicone-in-water cosmetic
    同族专利:
    公开号 | 公开日
    BE1025997A1|2019-09-04|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO2013109850A2|2012-01-19|2013-07-25|The Procter & Gamble Company|Methods for smoothing wrinkles and skin texture imperfections|
    法律状态:
    2019-11-27| FG| Patent granted|Effective date: 20191025 |
    优先权:
    申请号 | 申请日 | 专利标题
    EP18152341|2018-01-18|
    EP18152341.6|2018-01-18|
    [返回顶部]